Liggins Institute
Jo Perry
Senior Research Fellow
BSc (Hons), PhD
Contact details
Phone: +64 9 923 7873
Email: j.perry@auckland.ac.nz
Research interests
- Growth hormone
- Breast cancer
Dr Jo Perry graduated BSc (Hons) from Auckland University in 1991, and later completed a PhD in molecular biology at the Institute of Cancer Research in London, UK. Following a four year postdoctoral position investigating centromere biology at the Murdoch Children’s Research Institute in Melbourne she returned to New Zealand in 2005.
Development of resistance to cancer therapeutics is a major clinical challenge which has not yet been adequately addressed. Dr Perry’s current research interests involve the role of autocrine (locally secreted) human growth hormone (hGH) in the development and progression of breast cancer. Her research is also directed at studying the role of autocrine hGH in development of resistance to current anti-estrogen and chemotherapy-based breast cancer therapies.
1. Brunet-Dunand SE, Vouyovitch C, Araneda S, Pandey V, Vidal LJP, Print C, Mertani HC, Lobie PE, Perry JK. (2009) Autocrine human growth hormone promotes tumour angiogenesis in mammary carcinoma. Endocrinology, 150, 3, 1341-52.
2. Kang J, Perry JK, Pandey V, Fielder GC, Mei B, Qian P, Zhu T, Liu DX and Lobie PE. (2009) Artemin is oncogenic for human mammary carcinoma cells. Oncogene, 28, 19, 2034-45.
3. Pandey V, Perry JK, Mohan Kumar KM, Kun Y, Mitchell MD, Zhu T and Lobie PE. (2008) Autocrine Human Growth hormone stimulates oncogenicity of endometrial carcinoma cells. Endocrinology ,149, 8, 3909-3919.
4. Perry JK, Mohankumar KM, Emerald BS, Mertani HC and Lobie PE (2008) The contribution of growth hormone to mammary neoplasia. J Mamm Gland Biol Neoplasia, 13, 1, 131-45.
5. Perry J, Lobie P (2006) The oncogenic potential of growth hormone. GH and IGF-1 Research, 16, 5-6, 277-89.
-
SUPPORTING US
